UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-A
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR 12(g) OF
THE SECURITIES EXCHANGE ACT OF 1934
LOMBARD MEDICAL, INC.
(Exact name of registrant as specified in its charter)
| Cayman Islands | Not applicable | |
| (State of incorporation or organization) | (I.R.S. Employer Identification No.) | |
4 Trident Park Didcot Oxfordshire OX11 7HJ United Kingdom Tel: +44 20 1235 750800 | Not Applicable | |
| (Address of principal executive offices) | (Zip Code) | |
Securities to be registered pursuant to Section 12(b) of the Act:
Title of each class to be so registered | Name of each exchange on which each class is to be registered | |
| Ordinary Shares, par value $0.01 per share | The NASDAQ Stock Market LLC |
If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c), check the following box. x
If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d), check the following box. ¨
Securities Act registration statement file number to which this form relates:
333-194461 (If applicable)
Securities to be registered pursuant to Section 12(g) of the Act:
Not applicable
Item 1. Description of Registrant’s Securities to be Registered.
The description of the ordinary shares, par value $0.01 per share, of Lombard Medical, Inc. (the “Company”), as included under the caption “Description of Share Capital” in the prospectus forming a part of the Company’s Registration Statement onForm F-1 (Registration No. 333-194461), including exhibits and as amended (the “Registration Statement”), filed under the Securities Act of 1933, as amended (the “Securities Act”), with the Securities and Exchange Commission (the “Commission”), is hereby incorporated by reference. In addition, all of the above-referenced descriptions included in any prospectus relating to the Registration Statement filed with the Commission pursuant to Rule 424(b) under the Securities Act, shall be deemed to be incorporated by reference herein.
Item 2. Exhibits.
Pursuant to the Instructions as to Exhibits with respect toForm 8-A, no exhibits are required to be filed because no other securities of the Registrant are registered on The NASDAQ Stock Market LLC and the securities registered hereby are not being registered pursuant to Section 12 (g) of the Securities Exchange Act of 1934, as amended.
SIGNATURE
Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the Registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereto duly authorized.
| LOMBARD MEDICAL, INC. | ||
| By: | /s/ IAN ARDILL | |
| Name: Ian Ardill | ||
| Title: Chief Financial Officer | ||
Dated: April 7, 2014
